Stockholm Stock Exchange | Large Cap
Sobi
+13.05%
Latest
+9.99%
3 months
Deutsche BankNordea MarketsCarnegieMorningstarKepler CheuvreuxPareto SecuritiesJefferies InternationalBarclaysJefferiesDNBSEBDNB MarketsHandelsbanken Capital MarketsHandelsbankenDanske Bank MarketsSEB EquitiesABG Sundal Collier

About The Company

Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia